IS7297A - Streptococcis Pneumoniae vaccine - Google Patents

Streptococcis Pneumoniae vaccine

Info

Publication number
IS7297A
IS7297A IS7297A IS7297A IS7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A IS 7297 A IS7297 A IS 7297A
Authority
IS
Iceland
Prior art keywords
streptococcis
pneumoniae vaccine
pneumoniae
vaccine
streptococcis pneumoniae
Prior art date
Application number
IS7297A
Other languages
Icelandic (is)
Inventor
Anthony Joseph Laferriere Craig
Poolman Jan
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of IS7297A publication Critical patent/IS7297A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7297A 2001-12-18 2004-06-03 Streptococcis Pneumoniae vaccine IS7297A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (1)

Publication Number Publication Date
IS7297A true IS7297A (en) 2004-06-03

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7297A IS7297A (en) 2001-12-18 2004-06-03 Streptococcis Pneumoniae vaccine

Country Status (19)

Country Link
US (1) US20050214329A1 (en)
EP (1) EP1463519A2 (en)
JP (1) JP2005516932A (en)
KR (1) KR20040074091A (en)
CN (1) CN1635904A (en)
AU (1) AU2002361007A1 (en)
BR (1) BR0215089A (en)
CA (1) CA2470645A1 (en)
CO (1) CO5590937A2 (en)
GB (1) GB0130215D0 (en)
HU (1) HUP0402471A3 (en)
IL (1) IL162383A0 (en)
IS (1) IS7297A (en)
MX (1) MXPA04006073A (en)
NO (1) NO20043018L (en)
PL (1) PL370804A1 (en)
RU (1) RU2004117775A (en)
WO (1) WO2003051392A2 (en)
ZA (1) ZA200404803B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (en) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc MULTIVALENT VACCINE COMPOSITION WITH MIXED CARRIER
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425853A1 (en) * 2005-04-08 2012-03-07 Wyeth LLC Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
BRPI0620460B8 (en) * 2005-12-22 2021-05-25 Glaxosmithkline Biologicals Sa use of immunogenic composition for babies, and process to produce a vaccine
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
WO2007127668A2 (en) * 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
EP2059807B1 (en) * 2006-08-17 2013-02-20 The UAB Research Foundation Diagnosing pneumococcal pneumonia
CN1971275B (en) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 Method for detecting content of free polysaccharides in polysaccharides combo of pneumonia streptococcus 6B, 18C, 19F and 23F type
EA201490303A1 (en) * 2007-05-02 2014-05-30 Глаксосмитклайн Байолоджикалс С.А. VACCINE
BRPI0813644B8 (en) * 2007-06-26 2021-05-25 Glaxosmithkline Biologicals Sa immunogenic composition, vaccine, process to manufacture the same, and use of the immunogenic composition or vaccine
CN101802198B (en) * 2007-07-23 2016-02-17 圣诺菲·帕斯图尔有限公司 Immunogenic Peptides and Monoclonal Antibodies
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
WO2012075428A1 (en) 2010-12-03 2012-06-07 Sanofi Pasteur Limited Composition for immunization against streptococcus pneumoniae
MX354103B (en) * 2012-01-30 2018-02-13 Serum Inst India Ltd Immunogenic composition.
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
MX2015005002A (en) * 2012-10-17 2015-07-17 Glaxosmithkline Biolog Sa Immunogenic composition.
US12616744B2 (en) 2014-01-21 2026-05-05 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (en) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 A kind of compositions and preparation method and application
WO2018144799A1 (en) 2017-02-03 2018-08-09 SCHADECK, Eva, Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR20240018698A (en) * 2017-06-10 2024-02-13 인벤트프라이즈 인크. Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
EP3691677A4 (en) 2017-10-04 2021-07-07 Pogona, Llc SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHOD OF USING THEREOF
BR112020011414B8 (en) 2017-12-06 2023-01-31 Merck Sharp & Dohme MULTIVALENT IMMUNOGENIC COMPOSITIONS COMPRISING CARRIER PROTEIN AND POLYSACCHARIDE CONJUGATES FROM S. PNEUMONIAE
KR20230008923A (en) 2018-02-05 2023-01-16 사노피 파스퇴르 인코포레이티드 Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3782642A4 (en) * 2018-04-18 2022-04-13 SK Bioscience Co., Ltd. CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE AND IMMUNOGENIC CONJUGATES THEREOF
EP4192499A4 (en) 2020-08-10 2024-09-25 Inventprise, Inc. MULTIVALENT PNEUMOCOCCAL GLYCOCONJUGATE VACCINES CONTAINING AN EMERGING 24F SEROTYPE
KR20220102871A (en) * 2021-01-14 2022-07-21 (주)셀트리온 The immunogenic composition comprising multivalent pneumococcal polysaccharide-protein conjugate
CN118702827B (en) 2024-08-27 2025-03-07 南京澄实生物医药科技有限公司 A fusion protein for preventing pneumococcal infection and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (en) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc MULTIVALENT VACCINE COMPOSITION WITH MIXED CARRIER
JP2002539273A (en) * 1999-03-19 2002-11-19 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム vaccine

Also Published As

Publication number Publication date
AU2002361007A1 (en) 2003-06-30
HUP0402471A2 (en) 2005-03-29
PL370804A1 (en) 2005-05-30
CN1635904A (en) 2005-07-06
IL162383A0 (en) 2005-11-20
NO20043018L (en) 2004-07-15
EP1463519A2 (en) 2004-10-06
CO5590937A2 (en) 2005-12-30
RU2004117775A (en) 2005-04-20
ZA200404803B (en) 2005-08-29
WO2003051392A2 (en) 2003-06-26
GB0130215D0 (en) 2002-02-06
JP2005516932A (en) 2005-06-09
US20050214329A1 (en) 2005-09-29
CA2470645A1 (en) 2003-06-26
BR0215089A (en) 2004-11-16
KR20040074091A (en) 2004-08-21
WO2003051392A3 (en) 2003-11-13
HUP0402471A3 (en) 2005-04-28
MXPA04006073A (en) 2005-03-31

Similar Documents

Publication Publication Date Title
NO20043018L (en) Streptococcus pneumoniae vaccine
DK1390066T3 (en) vaccine Composition
NO20031483D0 (en) Vaccine
DK1427444T3 (en) WEST-NIL VACCINE
PL363005A1 (en) vaccines
EP1395727A4 (en) GARAGENSCHWENKTOR
ATE524462T1 (en) C5-MODIFIED INDAZOLYLPYRROLOTRIAZINES
NO20024172D0 (en) Vaccine
DE50103741D1 (en) Shaft-hub-connection
DE50206021D1 (en) SCHLAUCHKLEMME
NO20033882L (en) Vaccine
ATE335486T1 (en) HYDRAZONO-MALONITRILE
IS7317A (en) Imídasókínólínafleiður
ATA18372001A (en) GELENKSBOLZENBAUEINHEIT
ATA13992002A (en) SCHLACKENGRANULIERUNGSANLAGE
ATA17102002A (en) SPACER
DE60229395D1 (en) TION
DE50108381D1 (en) Synchronisierschaltungsanordnung
DE10295006D2 (en) Bauwerksabdichtung
NO20013661A (en) Fiskemerd
AT500276B8 (en) RADSCHWENKSYSTEM
ATE345337T1 (en) DELTA1 -PYRROLINES
ATA7462001A (en) Radspannwerk
ES1048085Y (en) CESTON
DE10142202B8 (en) Hochvakuumbedampfungsanlage